S-1 induced hepatic steatosis in patients with pancreatic cancer: Retrospective analysis

doi:10.4251/wjgo.v9.i8.314

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6347)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

298

WORD

228

HTML

2459

Figures (1-3)

190

Tables (1-2)

156

Sum=3331

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1234

Download

1782

Sum=3016

Aug 15, 2017 (publication date) through Jul 27, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Aug 15, 2017; 9(8): 314-318
Published online Aug 15, 2017. doi: 10.4251/wjgo.v9.i8.314

Full Size Figure Download Figure

Figure 2 Median liver/spleen ratios in pancreatic cancer patients before and after treatment with S-1. The ratio decreased significantly, from 1.27 before treatment to 1.09 after S-1 treatment (P = 0.012).

Citation: Tsuji K, Doyama H. S-1 induced hepatic steatosis in patients with pancreatic cancer: Retrospective analysis. World J Gastrointest Oncol 2017; 9(8): 314-318
URL: https://www.wjgnet.com/1948-5204/full/v9/i8/314.htm
DOI: https://dx.doi.org/10.4251/wjgo.v9.i8.314